Literature DB >> 24424062

Long- but not short-term adult-onset, isolated GH deficiency in male mice leads to deterioration of β-cell function, which cannot be accounted for by changes in β-cell mass.

Jose Cordoba-Chacon1, Manuel D Gahete, Naveen K Pokala, David Geldermann, Maria Alba, Roberto Salvatori, Raul M Luque, Rhonda D Kineman.   

Abstract

Developmental models of GH deficiency (GHD) and excess indicate that GH is positively associated with β-cell mass. Therefore, the reduction in GH levels observed with age and weight gain may contribute to the age-related decline in β-cell function. To test this hypothesis, β-cell mass and function were assessed in a mouse model of adult-onset, isolated GHD (AOiGHD). β-Cell mass did not differ between low-fat (LF)-fed AOiGHD and controls. However, high fat-fed AOiGHD mice displayed impaired expansion of β-cell mass and a reduction of bromodeoxyuridine-labeled islet cells, whereas in vitro β-cell function (basal and glucose-stimulated insulin secretion [GSIS]) did not differ from controls. In contrast, duration of AOiGHD differentially altered in vitro β-cell function in LF-fed mice. Specifically, islets from young LF-fed AOiGHD mice showed significant reductions in insulin content and basal insulin secretion, but GSIS was similar to that of controls. A similar islet phenotype was observed in a developmental model of isolated GHD (GH-releasing hormone knockout). Given that LF- and high fat-fed AOiGHD mice, as well as GH-releasing hormone knockout mice, display improved insulin sensitivity, islet changes may be due to reduced insulin demand, rather than primary β-cell dysfunction. However, islets from older LF-fed AOiGHD mice exhibited impaired GSIS, associated with reduced expression of genes important to maintain glucose sensing, suggesting that factors secondary to AOiGHD can alter β-cell function with age. AOiGHD mice exhibited postprandial hypertriglyceridemia and increased pancreatic expression of lipid/inflammatory stress response genes (activating transcription factor 3 and peroxisome proliferator activator receptor β/δ). Therefore, we speculate that these changes may initially protect the AOiGHD β-cell, but with age, lipotoxicity may impair β-cell function.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24424062      PMCID: PMC3929744          DOI: 10.1210/en.2013-1825

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  50 in total

Review 1.  Targeting PPARβ/δ for the treatment of type 2 diabetes mellitus.

Authors:  Laia Salvadó; Lucía Serrano-Marco; Emma Barroso; Xavier Palomer; Manuel Vázquez-Carrera
Journal:  Expert Opin Ther Targets       Date:  2012-01-27       Impact factor: 6.902

Review 2.  Idiopathic adult growth hormone deficiency.

Authors:  Shlomo Melmed
Journal:  J Clin Endocrinol Metab       Date:  2013-03-28       Impact factor: 5.958

3.  Expression profiling of palmitate- and oleate-regulated genes provides novel insights into the effects of chronic lipid exposure on pancreatic beta-cell function.

Authors:  Anna K Busch; Damien Cordery; Gareth S Denyer; Trevor J Biden
Journal:  Diabetes       Date:  2002-04       Impact factor: 9.461

4.  Growth hormone receptor regulates β cell hyperplasia and glucose-stimulated insulin secretion in obese mice.

Authors:  Yingjie Wu; Chengyu Liu; Hui Sun; Archana Vijayakumar; Pejman Raeisi Giglou; Ruifang Qiao; Joshua Oppenheimer; Shoshana Yakar; Derek LeRoith
Journal:  J Clin Invest       Date:  2011-05-09       Impact factor: 14.808

5.  Pancreatic β-cells activate a JunB/ATF3-dependent survival pathway during inflammation.

Authors:  E N Gurzov; J Barthson; I Marhfour; F Ortis; N Naamane; M Igoillo-Esteve; C Gysemans; C Mathieu; S Kitajima; P Marchetti; T F Ørntoft; L Bakiri; E F Wagner; D L Eizirik
Journal:  Oncogene       Date:  2011-08-15       Impact factor: 9.867

6.  The roles of ATF3, an adaptive-response gene, in high-fat-diet-induced diabetes and pancreatic beta-cell dysfunction.

Authors:  Erik J Zmuda; Ling Qi; Michael X Zhu; Raghavendra G Mirmira; Marc R Montminy; Tsonwin Hai
Journal:  Mol Endocrinol       Date:  2010-06-02

Review 7.  Growth hormone inhibits its own secretion by acting on the hypothalamus through its receptors on neuropeptide Y neurons in the arcuate nucleus and somatostatin neurons in the periventricular nucleus.

Authors:  S Minami; J Kamegai; H Sugihara; N Suzuki; I Wakabayashi
Journal:  Endocr J       Date:  1998-04       Impact factor: 2.349

8.  Impact of obesity on the growth hormone axis: evidence for a direct inhibitory effect of hyperinsulinemia on pituitary function.

Authors:  Raul M Luque; Rhonda D Kineman
Journal:  Endocrinology       Date:  2006-03-02       Impact factor: 4.736

9.  Lack of evidence of premature atherosclerosis in untreated severe isolated growth hormone (GH) deficiency due to a GH-releasing hormone receptor mutation.

Authors:  Joselina Luzia Menezes Oliveira; Celi Marques-Santos; José Augusto Barreto-Filho; Roberto Ximenes Filho; Allan Valadão de Oliveira Britto; Anita Hermínia Oliveira Souza; Clarisse Miranda Prado; Carla Raquel Pereira Oliveira; Rossana Maria C Pereira; Tábita de Almeida Ribeiro Vicente; Catarine Teles Farias; Manuel Hermínio Aguiar-Oliveira; Roberto Salvatori
Journal:  J Clin Endocrinol Metab       Date:  2006-03-07       Impact factor: 5.958

10.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.

Authors:  Jo Vandesompele; Katleen De Preter; Filip Pattyn; Bruce Poppe; Nadine Van Roy; Anne De Paepe; Frank Speleman
Journal:  Genome Biol       Date:  2002-06-18       Impact factor: 13.583

View more
  11 in total

1.  Differential impact of selective GH deficiency and endogenous GH excess on insulin-mediated actions in muscle and liver of male mice.

Authors:  Jose Cordoba-Chacon; Manuel D Gahete; Owen P McGuinness; Rhonda D Kineman
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-09-30       Impact factor: 4.310

2.  Hepatocyte-specific, PPARγ-regulated mechanisms to promote steatosis in adult mice.

Authors:  Abigail Wolf Greenstein; Neena Majumdar; Peng Yang; Papasani V Subbaiah; Rhonda D Kineman; Jose Cordoba-Chacon
Journal:  J Endocrinol       Date:  2016-10-31       Impact factor: 4.286

3.  Loss of growth hormone signaling in the mouse germline or in adulthood reduces islet mass and alters islet function with notable sex differences.

Authors:  Silvana Duran-Ortiz; Kathryn L Corbin; Ishrat Jahan; Nicholas B Whitticar; Sarah E Morris; Ania N Bartholomew; Kira G Slepchenko; Hannah L West; Ibiagbani Mercy Max Harry; Edward O List; John J Kopchick; Craig S Nunemaker
Journal:  Am J Physiol Endocrinol Metab       Date:  2021-05-03       Impact factor: 5.900

4.  Effect of oral glucose administration on rebound growth hormone release in normal and obese women: the role of adiposity, insulin sensitivity and ghrelin.

Authors:  Lara Pena-Bello; Sonia Pertega-Diaz; Elena Outeiriño-Blanco; Jesus Garcia-Buela; Sulay Tovar; Susana Sangiao-Alvarellos; Carlos Dieguez; Fernando Cordido
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

5.  Type 2 Diabetes Mellitus, a Sequel of Untreated Childhood Onset Growth Hormone Deficiency Developing in a 17-Year-Old Patient.

Authors:  Rohan K Henry; Ram K Menon
Journal:  Case Rep Endocrinol       Date:  2018-10-24

6.  Late-life targeting of the IGF-1 receptor improves healthspan and lifespan in female mice.

Authors:  Kai Mao; Gabriela Farias Quipildor; Tahmineh Tabrizian; Ardijana Novaj; Fangxia Guan; Ryan O Walters; Fabien Delahaye; Gene B Hubbard; Yuji Ikeno; Keisuke Ejima; Peng Li; David B Allison; Hossein Salimi-Moosavi; Pedro J Beltran; Pinchas Cohen; Nir Barzilai; Derek M Huffman
Journal:  Nat Commun       Date:  2018-06-19       Impact factor: 14.919

7.  Growth hormone receptor gene disruption in mature-adult mice improves male insulin sensitivity and extends female lifespan.

Authors:  Silvana Duran-Ortiz; Edward O List; Yuji Ikeno; Jonathan Young; Reetobrata Basu; Stephen Bell; Todd McHugh; Kevin Funk; Samuel Mathes; Yanrong Qian; Prateek Kulkarni; Shoshana Yakar; Darlene E Berryman; John J Kopchick
Journal:  Aging Cell       Date:  2021-11-22       Impact factor: 9.304

Review 8.  Towards Understanding the Direct and Indirect Actions of Growth Hormone in Controlling Hepatocyte Carbohydrate and Lipid Metabolism.

Authors:  Mari C Vázquez-Borrego; Mercedes Del Rio-Moreno; Rhonda D Kineman
Journal:  Cells       Date:  2021-09-24       Impact factor: 6.600

9.  GH directly inhibits steatosis and liver injury in a sex-dependent and IGF1-independent manner.

Authors:  Andre Sarmento-Cabral; Mercedes Del Rio-Moreno; Mari C Vazquez-Borrego; Mariyah Mahmood; Elena Gutierrez-Casado; Natalie Pelke; Grace Guzman; Papasani V Subbaiah; Jose Cordoba-Chacon; Shoshana Yakar; Rhonda D Kineman
Journal:  J Endocrinol       Date:  2021-01       Impact factor: 4.286

10.  Sexual dimorphic impact of adult-onset somatopause on life span and age-induced osteoarthritis.

Authors:  Sher Bahadur Poudel; Manisha Dixit; Gozde Yildirim; Jose Cordoba-Chacon; Manuel D Gahete; Ikeno Yuji; Thorsten Kirsch; Rhonda D Kineman; Shoshana Yakar
Journal:  Aging Cell       Date:  2021-07-09       Impact factor: 9.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.